IL96161A - Use of 1-Oxides of -N Methyl-2- (3-Pyridyl) -Tetrahydrotheopyran-2 for the preparation of medical products for the treatment of renal artery failure - Google Patents

Use of 1-Oxides of -N Methyl-2- (3-Pyridyl) -Tetrahydrotheopyran-2 for the preparation of medical products for the treatment of renal artery failure

Info

Publication number
IL96161A
IL96161A IL9616190A IL9616190A IL96161A IL 96161 A IL96161 A IL 96161A IL 9616190 A IL9616190 A IL 9616190A IL 9616190 A IL9616190 A IL 9616190A IL 96161 A IL96161 A IL 96161A
Authority
IL
Israel
Prior art keywords
methyl
pyridyl
oxide
carbothioamide
preparation
Prior art date
Application number
IL9616190A
Other languages
English (en)
Hebrew (he)
Other versions
IL96161A0 (en
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of IL96161A0 publication Critical patent/IL96161A0/xx
Publication of IL96161A publication Critical patent/IL96161A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9616190A 1989-10-31 1990-10-29 Use of 1-Oxides of -N Methyl-2- (3-Pyridyl) -Tetrahydrotheopyran-2 for the preparation of medical products for the treatment of renal artery failure IL96161A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8914272A FR2653662B1 (fr) 1989-10-31 1989-10-31 Application du n-methyl (pyridyl-3)-2 tetrahydrothiopyranne-carbothioamide-2-oxyde-1 a la preparation de medicaments destines au traitement de l'insuffisance coronarienne.

Publications (2)

Publication Number Publication Date
IL96161A0 IL96161A0 (en) 1991-07-18
IL96161A true IL96161A (en) 1996-12-05

Family

ID=9386962

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9616190A IL96161A (en) 1989-10-31 1990-10-29 Use of 1-Oxides of -N Methyl-2- (3-Pyridyl) -Tetrahydrotheopyran-2 for the preparation of medical products for the treatment of renal artery failure

Country Status (17)

Country Link
US (1) US5426117A (de)
EP (1) EP0429324B1 (de)
JP (1) JPH03153683A (de)
KR (1) KR910007524A (de)
AT (1) ATE135910T1 (de)
AU (1) AU637419B2 (de)
CA (1) CA2028986A1 (de)
DE (1) DE69026204T2 (de)
DK (1) DK0429324T3 (de)
ES (1) ES2084679T3 (de)
FR (1) FR2653662B1 (de)
GR (1) GR3019441T3 (de)
HU (1) HU212502B (de)
IE (1) IE72476B1 (de)
IL (1) IL96161A (de)
PT (1) PT95757B (de)
ZA (1) ZA908678B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100373173B1 (ko) * 1996-11-18 2003-08-19 주식회사 코오롱 차광성 및 성형성이 우수한 폴리에틸렌테레프탈레이트 수지 조성물
KR102068928B1 (ko) * 2019-05-17 2020-01-21 민은홍 광고수단으로 전환사용이 가능한 레일 조명

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2528849B1 (fr) * 1982-06-17 1985-06-21 Rhone Poulenc Sante Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
FR2653662A1 (fr) 1991-05-03
ATE135910T1 (de) 1996-04-15
ES2084679T3 (es) 1996-05-16
HU212502B (en) 1996-07-29
IE903901A1 (en) 1991-05-08
GR3019441T3 (en) 1996-06-30
CA2028986A1 (fr) 1991-05-01
EP0429324A3 (en) 1992-05-27
AU6554790A (en) 1991-05-09
DE69026204T2 (de) 1996-09-05
DE69026204D1 (de) 1996-05-02
FR2653662B1 (fr) 1994-05-13
EP0429324A2 (de) 1991-05-29
ZA908678B (en) 1991-08-28
HUT59312A (en) 1992-05-28
KR910007524A (ko) 1991-05-30
PT95757A (pt) 1991-09-13
IL96161A0 (en) 1991-07-18
DK0429324T3 (da) 1996-04-29
US5426117A (en) 1995-06-20
EP0429324B1 (de) 1996-03-27
HU906946D0 (en) 1991-05-28
AU637419B2 (en) 1993-05-27
JPH03153683A (ja) 1991-07-01
IE72476B1 (en) 1997-04-23
PT95757B (pt) 1997-09-30

Similar Documents

Publication Publication Date Title
US5393772A (en) Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation
US5480888A (en) Inhibitor for restenosis after percutaneous coronary arterioplasty
KR0148645B1 (ko) 심장 보호제
WO1988005044A1 (en) Nitroxide compounds for the preparation of a pharmaceutical composition intended for the prophylaxis and treatment of ischemic cell damage
SK287533B6 (sk) Liečivo na liečenie viacpočetných rezistentných nádorov alebo na inhibíciu angiogenézy a metastáz
CN115605210A (zh) 用于治疗心律失常的烟酰胺单核苷酸和双烟酰胺二核苷酸衍生物
EP0682947B1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
JP4306825B2 (ja) インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US5426117A (en) N-methyl-2-(3-pyridyl)-tetrahydrothio-pyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for treatment of coronary insufficiency
JPS62114977A (ja) 強心剤チアゾロン類
JPWO2004089412A1 (ja) 特異的nad(p)hオキシダーゼ抑制剤
KR900006993B1 (ko) 아테롬성 동맥경화증 치료제로서의 dl-5-[(2-벤질-3,4-디하이드로-2H-벤조피란-6-일)메틸]티아졸리딘-2,4-디온
GB2252498A (en) Benzoyl carbinol and its esters, useful as inhibitors of angiogenesis
WO1994005290A1 (fr) Inhibiteur d'agregation plaquettaire
US4418070A (en) Cardiotonic agents
US6479676B1 (en) OxiranEcarboxylic acids for the treatment of diabetes
EP0429676B1 (de) Arzneimittel für bessere gehirnwirkung
AU701287B2 (en) The pharmacological use of certain cystine derivatives
US3749781A (en) Pharmaceutical composition and method of treatment
US3824315A (en) Method of treatment
KR20070029133A (ko) 혈관 내막 비후 억제약
RU2093149C1 (ru) Фармацевтическая композиция для лечения или профилактики гипертонии, связанной с тучностью
CA1274176A (en) Therapeutic compositions containing carboxylic azetidine derivatives
Stauch et al. Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate: Interaction of nitrate and gallopamil
WO2025207099A1 (en) Ppar-delta inhibitors for preventing post-operative atrial fibrillation

Legal Events

Date Code Title Description
RH Patent void